NZ598172A - Synthesis of boronic ester and acid compounds - Google Patents

Synthesis of boronic ester and acid compounds

Info

Publication number
NZ598172A
NZ598172A NZ598172A NZ59817205A NZ598172A NZ 598172 A NZ598172 A NZ 598172A NZ 598172 A NZ598172 A NZ 598172A NZ 59817205 A NZ59817205 A NZ 59817205A NZ 598172 A NZ598172 A NZ 598172A
Authority
NZ
New Zealand
Prior art keywords
compound
formula
synthesis
acid compounds
boronic ester
Prior art date
Application number
NZ598172A
Other languages
English (en)
Inventor
Fraser I Pickersgill
John Bishop
Christoph Koellner
Achim Geiser
Robert Hett
Vince Ammoscato
Stephen Munk
Young Lo
Jean-Marc Gomez
Fang Ting Chui
Vuithalanand R Kulkarni
Original Assignee
Millennium Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34968044&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NZ598172(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Millennium Pharm Inc filed Critical Millennium Pharm Inc
Publication of NZ598172A publication Critical patent/NZ598172A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/04—Esters of boric acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
NZ598172A 2004-03-30 2005-03-24 Synthesis of boronic ester and acid compounds NZ598172A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55753504P 2004-03-30 2004-03-30
NZ586824A NZ586824A (en) 2004-03-30 2005-03-24 Synthesis of boronic ester and acid compounds

Publications (1)

Publication Number Publication Date
NZ598172A true NZ598172A (en) 2013-08-30

Family

ID=34968044

Family Applications (3)

Application Number Title Priority Date Filing Date
NZ598172A NZ598172A (en) 2004-03-30 2005-03-24 Synthesis of boronic ester and acid compounds
NZ550522A NZ550522A (en) 2004-03-30 2005-03-24 Synthesis of boronic ester and acid compounds
NZ586824A NZ586824A (en) 2004-03-30 2005-03-24 Synthesis of boronic ester and acid compounds

Family Applications After (2)

Application Number Title Priority Date Filing Date
NZ550522A NZ550522A (en) 2004-03-30 2005-03-24 Synthesis of boronic ester and acid compounds
NZ586824A NZ586824A (en) 2004-03-30 2005-03-24 Synthesis of boronic ester and acid compounds

Country Status (41)

Country Link
US (14) US7714159B2 (cg-RX-API-DMAC7.html)
EP (5) EP2377869B1 (cg-RX-API-DMAC7.html)
JP (4) JP4558039B2 (cg-RX-API-DMAC7.html)
KR (1) KR100939598B1 (cg-RX-API-DMAC7.html)
CN (5) CN111925385B (cg-RX-API-DMAC7.html)
AR (3) AR049374A1 (cg-RX-API-DMAC7.html)
AT (1) ATE521612T1 (cg-RX-API-DMAC7.html)
AU (1) AU2005230930B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0509587A (cg-RX-API-DMAC7.html)
CA (4) CA2853272A1 (cg-RX-API-DMAC7.html)
CL (2) CL2010000350A1 (cg-RX-API-DMAC7.html)
CR (1) CR8653A (cg-RX-API-DMAC7.html)
CY (3) CY1112053T1 (cg-RX-API-DMAC7.html)
DK (4) DK1756121T3 (cg-RX-API-DMAC7.html)
DO (1) DOP2011000293A (cg-RX-API-DMAC7.html)
EA (1) EA012927B1 (cg-RX-API-DMAC7.html)
EC (1) ECSP066960A (cg-RX-API-DMAC7.html)
ES (4) ES2899606T3 (cg-RX-API-DMAC7.html)
FI (1) FI4008721T3 (cg-RX-API-DMAC7.html)
HK (1) HK1246300A1 (cg-RX-API-DMAC7.html)
HR (4) HRP20110846T1 (cg-RX-API-DMAC7.html)
HU (2) HUE065769T2 (cg-RX-API-DMAC7.html)
IL (3) IL178250A (cg-RX-API-DMAC7.html)
LT (2) LT4008721T (cg-RX-API-DMAC7.html)
ME (1) ME01975B (cg-RX-API-DMAC7.html)
MX (1) MX367324B (cg-RX-API-DMAC7.html)
MY (1) MY145427A (cg-RX-API-DMAC7.html)
NL (3) NL1028639C2 (cg-RX-API-DMAC7.html)
NO (4) NO338905B1 (cg-RX-API-DMAC7.html)
NZ (3) NZ598172A (cg-RX-API-DMAC7.html)
PE (3) PE20060162A1 (cg-RX-API-DMAC7.html)
PL (4) PL2377869T3 (cg-RX-API-DMAC7.html)
PT (4) PT3385267T (cg-RX-API-DMAC7.html)
RS (4) RS53259B (cg-RX-API-DMAC7.html)
SG (5) SG10201600029PA (cg-RX-API-DMAC7.html)
SI (4) SI3385267T1 (cg-RX-API-DMAC7.html)
TW (1) TWI386212B (cg-RX-API-DMAC7.html)
UA (1) UA90108C2 (cg-RX-API-DMAC7.html)
UY (3) UY28830A1 (cg-RX-API-DMAC7.html)
WO (1) WO2005097809A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200608689B (cg-RX-API-DMAC7.html)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083903A (en) * 1994-10-28 2000-07-04 Leukosite, Inc. Boronic ester and acid compounds, synthesis and uses
ES2899606T3 (es) 2004-03-30 2022-03-14 Millennium Pharm Inc Síntesis de compuestos de ésteres y ácidos borónicos
WO2008075376A1 (en) * 2006-12-18 2008-06-26 Natco Pharma Limited Polymorphic forms of bortezomib and process for their preparation
WO2009004350A1 (en) * 2007-07-03 2009-01-08 Pliva Hrvatska D.O.O. Methods for preparing bortezomib and intermediates used in its manufacture
KR20140042933A (ko) * 2007-08-06 2014-04-07 밀레니엄 파머슈티컬스 인코퍼레이티드 프로테아좀 억제제
US7442830B1 (en) 2007-08-06 2008-10-28 Millenium Pharmaceuticals, Inc. Proteasome inhibitors
AU2016253697A1 (en) * 2007-08-06 2016-11-24 Millennium Pharmaceuticals, Inc. Proteasome inhibitors
EA034601B1 (ru) * 2007-08-06 2020-02-25 Милленниум Фармасьютикалз, Инк. Способ получения бороновых кислот
US20110118274A1 (en) * 2007-08-23 2011-05-19 Cornell Research Foundation, Inc. Proteasome inhibitors and their use in treating pathogen infection and cancer
BRPI0816807A2 (pt) * 2007-09-12 2017-05-16 Dr Reddy's Laboratories Inc bortezomib e processo para a produção do mesmo
US7838673B2 (en) 2007-10-16 2010-11-23 Millennium Pharmaceuticals, Inc. Proteasome inhibitors
SI2318419T2 (sl) 2008-06-17 2025-10-30 Takeda Pharmaceutical Company Limited Spojine boronat estra in njihovi farmacevtski sestavki
AU2013204896A1 (en) * 2008-09-29 2013-05-16 Millennium Pharmaceuticals, Inc. Derivatives of 1-amino-2-cyclobutylethylboronic acid
AR075090A1 (es) 2008-09-29 2011-03-09 Millennium Pharm Inc Derivados de acido 1-amino-2-ciclobutiletilboronico inhibidores de proteosoma,utiles como agentes anticancerigenos, y composiciones farmaceuticas que los comprenden.
EP2238973A1 (en) 2009-04-07 2010-10-13 Cephalon France Lyophilized preparations of proteasome inhibitors
CN101899062B (zh) * 2009-05-26 2015-04-15 上海威智医药科技有限公司 α-手性硼酸及硼酸酯的合成工艺
JP2012530116A (ja) 2009-06-19 2012-11-29 レツク・フアーマシユーテイカルズ・デー・デー 脱ハロゲン化なしにハロゲノアルケンを水素化する方法
EP2270019A1 (en) 2009-06-19 2011-01-05 LEK Pharmaceuticals d.d. New synthetic route for the preparation of alpha-amino boronic esters
EP2280016A1 (en) 2009-07-27 2011-02-02 LEK Pharmaceuticals d.d. New synthetic route for the preparation of alpha-amino boronic esters via substituted alk-1-ynes
NZ600786A (en) 2009-12-22 2013-12-20 Cephalon Inc Proteasome inhibitors and processes for their preparation, purification and use
WO2011090940A1 (en) 2010-01-19 2011-07-28 Cerulean Pharma Inc. Cyclodextrin-based polymers for therapeutic delivery
WO2011098963A1 (en) 2010-02-09 2011-08-18 Ranbaxy Laboratories Limited Process for the preparation of bortezomib
CN101781326B (zh) * 2010-02-11 2013-08-21 福建南方制药股份有限公司 一种制备手性氨基硼酸的中间体及其制备方法
WO2011107912A1 (en) 2010-03-04 2011-09-09 Ranbaxy Laboratories Limited Polymorphic forms of bortezomib
RU2529800C2 (ru) * 2010-03-18 2014-09-27 ИННОФАРМА, Инк. Стабильные составы бортезомиба
US8263578B2 (en) 2010-03-18 2012-09-11 Innopharma, Inc. Stable bortezomib formulations
AU2011235227B2 (en) 2010-03-31 2016-09-08 Millennium Pharmaceuticals, Inc. Derivatives of 1-amino-2-cyclopropylethylboronic acid
CN101812026B (zh) * 2010-04-12 2013-08-28 亚邦医药股份有限公司 一种硼替佐米的合成方法
CA2927832C (en) 2010-05-18 2021-03-23 Cerulean Pharma Inc. Cyclodextrin-containing polymer-therapeutic agent conjugates and their use
ES2548256T3 (es) 2010-10-14 2015-10-15 Synthon Bv Proceso para la preparación de bortezomib y los intermedios para el proceso
TW201309303A (zh) 2011-03-03 2013-03-01 Cephalon Inc 用於治療狼瘡的蛋白酶體抑制劑
CN102206188B (zh) * 2011-04-08 2013-02-27 苏州二叶制药有限公司 N-(吡嗪-2-基羰基)-l-苯丙氨酸的制备方法
US8497374B2 (en) 2011-05-12 2013-07-30 Scinopharm Taiwan, Ltd. Process for preparing and purifying bortezomib
CN102268029B (zh) * 2011-05-19 2013-10-09 苏州二叶制药有限公司 化合物(1s,2s,3r,5s)-蒎烷二醇-l-苯丙氨酸-l-亮氨酸硼酸酯的制备
WO2012177835A1 (en) 2011-06-22 2012-12-27 Cephalon, Inc. Proteasome inhibitors and processes for their preparation, purification and use
CN102351890B (zh) * 2011-09-30 2014-07-02 重庆泰濠制药有限公司 一种硼替佐米的合成方法
CN102492021B (zh) * 2011-12-13 2013-10-23 重庆泰濠制药有限公司 硼替佐米的制备工艺
SG10201605152SA (en) 2011-12-22 2016-08-30 Ares Trading Sa Alpha-amino boronic acid derivatives, selective immunoproteasome inhibitors
CN103374026A (zh) * 2012-04-27 2013-10-30 重庆医药工业研究院有限责任公司 一种硼替佐米中间体的制备方法
CN103450331B (zh) * 2012-06-05 2016-05-25 山东新时代药业有限公司 一种硼替佐米的精制方法
CA2884292A1 (en) * 2012-09-11 2014-03-20 Cipla Limited Process for preparing of bortezomib
WO2014072985A1 (en) 2012-11-06 2014-05-15 Natco Pharma Limited Novel boronic acid derivatives as anti cancer agents
EP2919786A4 (en) 2012-11-16 2016-06-01 Shilpa Medicare Ltd Crystalline bortezomib process
JP6403219B2 (ja) 2012-12-07 2018-10-10 ベナトルクス ファーマシューティカルズ,インク. ベータ−ラクタマーゼ阻害剤
CN103897026A (zh) * 2012-12-29 2014-07-02 朱继东 硼替佐米关键中间体的晶型,制备方法及其运用
CN103897027A (zh) * 2012-12-29 2014-07-02 曹亚英 关键中间体晶型,制备方法及其在硼替佐米合成中的运用
CN105101970B (zh) 2013-01-10 2018-11-20 维纳拓尔斯制药公司 β-内酰胺酶抑制剂
US10023611B2 (en) 2013-04-16 2018-07-17 Cipla Limited Process for the preparation of bortezomib mannitol ester
CN104211758B (zh) * 2013-05-29 2020-06-12 深圳翰宇药业股份有限公司 一种硼替佐米的制备方法
CN103497233B (zh) * 2013-09-30 2015-04-08 哈药集团技术中心 一种硼替佐米的制备方法
CN103554219A (zh) * 2013-10-01 2014-02-05 昆明贵研药业有限公司 一种制备硼替佐米的方法
KR101691353B1 (ko) * 2013-12-09 2016-12-30 주식회사 경보제약 보르테조밉의 제조방법 및 그의 신규 중간체
CN106132970B (zh) 2014-02-03 2020-09-04 俄亥俄州创新基金会 硼酸酯和其药物制剂
UA121389C2 (uk) 2014-05-20 2020-05-25 Мілленніум Фармасьютікалз, Інк. Борвмісні інгібітори протеасом для застосування після первинної протиракової терапії
KR102396753B1 (ko) 2014-06-11 2022-05-12 베나토알엑스 파마슈티컬스, 인크. 베타-락타마제 억제제
JP6420629B2 (ja) * 2014-10-30 2018-11-07 ボーグワーナー インコーポレーテッド チェーンガイドおよびチェーンテンショナアーム
DE102015204151B4 (de) * 2015-03-09 2025-12-24 Adidas Ag Ball, insbesondere Fußball, und Verfahren zur Herstellung eines Balls
JP6223508B2 (ja) * 2016-06-27 2017-11-01 ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. プロテアソーム阻害剤
EP3494121B1 (en) 2016-08-04 2021-10-06 Venatorx Pharmaceuticals, Inc. Boron-containing compounds
EP3583110A1 (en) 2017-02-17 2019-12-25 Fresenius Kabi Oncology Ltd An improved process for the preparation of boronic acid esters
PH12019502037B1 (en) 2017-03-06 2024-06-05 Everest Medicines Singapore Pte Ltd Solid forms and combination compositions comprising a beta-lactamase inhibitor and uses thereof
EP3630782A4 (en) 2017-05-26 2021-03-03 Venatorx Pharmaceuticals, Inc. Penicillin-binding protein inhibitors
US11267826B2 (en) 2017-05-26 2022-03-08 VenatoRx Pharmaceuticals, Inc. Penicillin-binding protein inhibitors
CN109305980B (zh) 2017-07-28 2022-10-11 成都奥璟生物科技有限公司 一种硼酸酯化合物、其合成方法及其用途
EP3676272A4 (en) * 2017-09-02 2021-04-21 Sun Pharmaceutical Industries Limited IXAZOMIB CITRATE PREPARATION PROCESS
US12173018B2 (en) 2018-05-25 2024-12-24 VenatoRx Pharmaceuticals, Inc. Penicillin-binding protein inhibitors
CN111187336B (zh) * 2018-11-14 2022-05-20 正大天晴药业集团股份有限公司 硼替佐米的精制方法
DK3886798T3 (da) 2018-11-29 2026-04-20 Basilea Pharmaceutica Int Ag Allschwil Kombinationssammensætninger, som omfatter en beta-lactamase-hæmmer, og anvendelser deraf
US11964993B2 (en) 2021-07-03 2024-04-23 Shilpa Pharma Lifesciences Limited Crystalline bortezomib process
US20250059215A1 (en) 2023-08-07 2025-02-20 Tae Life Sciences Llc Trifluoroborate (BF3) Compositions For Use In Boron Neutron Capture Therapy and Methods Thereof
EP4791750A1 (en) * 2023-10-13 2026-08-19 The Brigham & Women's Hospital, Inc. Proteasome inhibitors and methods of use thereof
CN120248757A (zh) * 2025-05-28 2025-07-04 滁州瑞达新能源材料有限公司 一种自清洁耐候的铝合金光伏组件边框及其制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL31992A (en) * 1968-05-08 1973-07-30 American Cyanamid Co Synthetic thyrocalcitonins and method of making them
ZA794723B (en) * 1978-09-11 1980-08-27 Univ Miami Anti-hypertensive agents
US4525309A (en) * 1983-03-15 1985-06-25 Washington State University Research Foundation, Inc. Lewis acid catalysis of the homologation of boronic esters with haloalkylmetal reagents
US4499082A (en) 1983-12-05 1985-02-12 E. I. Du Pont De Nemours And Company α-Aminoboronic acid peptides
US4537773A (en) 1983-12-05 1985-08-27 E. I. Du Pont De Nemours And Company α-Aminoboronic acid derivatives
ES542440A0 (es) * 1985-04-22 1985-12-16 Inke Sa "procedimiento para la obtencion del ester benzilico de 1-(n-(1--etoxicarbonil-3-oxo-fenilpropil)-l-alanil)-l-prolina".
SE8506094D0 (sv) * 1985-12-20 1985-12-20 Astra Laekemedel Ab New antibacterial agents and intermediates therefor
US4701545A (en) * 1986-02-12 1987-10-20 Washington State University Research Foundation, Inc. Preparation of α,α-dihaloalkyl boronic esters
US5250720A (en) 1987-06-05 1993-10-05 The Dupont Merck Pharmaceutical Company Intermediates for preparing peptide boronic acid inhibitors of trypsin-like proteases
US5242904A (en) 1987-06-05 1993-09-07 The Dupont Merck Pharmaceutical Company Peptide boronic acid inhibitors of trypsin-like proteases
US5187157A (en) * 1987-06-05 1993-02-16 Du Pont Merck Pharmaceutical Company Peptide boronic acid inhibitors of trypsin-like proteases
EP0315574A3 (de) 1987-11-05 1990-08-22 Hoechst Aktiengesellschaft Renin-Inhibitoren
US5106948A (en) 1988-05-27 1992-04-21 Mao Foundation For Medical Education And Research Cytotoxic boronic acid peptide analogs
US6083903A (en) 1994-10-28 2000-07-04 Leukosite, Inc. Boronic ester and acid compounds, synthesis and uses
CA2435146C (en) * 2001-01-25 2011-03-29 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Formulation of boronic acid compounds
WO2003033506A1 (en) * 2001-10-12 2003-04-24 Kyorin Pharmaceutical Co., Ltd. Aminoborane acid derivative and proteasome inhibitory drug containing the same
WO2003033507A1 (en) * 2001-10-12 2003-04-24 Kyorin Pharmaceutical Co., Ltd. Benzylmalonic acid derivatives and proteasome inhibitors contaiing the same
ES2899606T3 (es) * 2004-03-30 2022-03-14 Millennium Pharm Inc Síntesis de compuestos de ésteres y ácidos borónicos
WO2009004350A1 (en) * 2007-07-03 2009-01-08 Pliva Hrvatska D.O.O. Methods for preparing bortezomib and intermediates used in its manufacture
US7838673B2 (en) * 2007-10-16 2010-11-23 Millennium Pharmaceuticals, Inc. Proteasome inhibitors
JP2012530116A (ja) * 2009-06-19 2012-11-29 レツク・フアーマシユーテイカルズ・デー・デー 脱ハロゲン化なしにハロゲノアルケンを水素化する方法

Also Published As

Publication number Publication date
US20210395301A1 (en) 2021-12-23
PT1756121E (pt) 2011-11-30
ZA200608689B (en) 2007-09-26
US20200369722A1 (en) 2020-11-26
SI1756121T1 (sl) 2012-03-30
PE20142402A1 (es) 2015-02-04
IL178250A0 (en) 2006-12-31
RS51983B (sr) 2012-02-29
US20130005968A1 (en) 2013-01-03
CY1124753T1 (el) 2022-07-22
US20180044377A1 (en) 2018-02-15
EP2377868A1 (en) 2011-10-19
US20100174072A1 (en) 2010-07-08
ES2371652T3 (es) 2012-01-05
NL1033190C2 (nl) 2007-11-27
JP5894952B2 (ja) 2016-03-30
RS65253B1 (sr) 2024-03-29
CL2014002252A1 (es) 2014-12-05
US20180265546A1 (en) 2018-09-20
AU2005230930B2 (en) 2011-09-29
SG182998A1 (en) 2012-08-30
NO344610B1 (no) 2020-02-10
JP2010241816A (ja) 2010-10-28
US20210171574A1 (en) 2021-06-10
NZ586824A (en) 2012-03-30
HRP20212002T1 (hr) 2022-04-01
ME01975B (me) 2015-05-20
CN1960996A (zh) 2007-05-09
WO2005097809A2 (en) 2005-10-20
AR097309A2 (es) 2016-03-02
IL219856A0 (en) 2012-06-28
BRPI0509587A (pt) 2007-09-25
ECSP066960A (es) 2006-12-20
SI4008721T1 (sl) 2024-05-31
CA2738706C (en) 2014-10-14
SG10201600029PA (en) 2016-02-26
JP2007530687A (ja) 2007-11-01
LT3385267T (lt) 2021-11-10
CA2859119A1 (en) 2005-10-20
MY145427A (en) 2012-02-15
KR20070007873A (ko) 2007-01-16
CA2560886C (en) 2014-08-12
RS53259B (sr) 2014-08-29
DK3385267T3 (da) 2021-11-01
SG151322A1 (en) 2009-04-30
SI3385267T1 (sl) 2022-04-29
US20160362449A1 (en) 2016-12-15
NO20064893L (no) 2006-12-22
PT4008721T (pt) 2024-03-21
EA012927B1 (ru) 2010-02-26
SG182999A1 (en) 2012-08-30
PL4008721T3 (pl) 2024-05-13
CN111925385A (zh) 2020-11-13
DK4008721T3 (da) 2024-03-25
JP6193960B2 (ja) 2017-09-06
SI2377869T1 (sl) 2014-05-30
EP2377869A1 (en) 2011-10-19
HUE056859T2 (hu) 2022-03-28
CY1112053T1 (el) 2015-11-04
CN111925385B (zh) 2023-11-21
CR8653A (es) 2007-10-23
IL178250A (en) 2012-06-28
US20050240047A1 (en) 2005-10-27
HRP20240307T3 (hr) 2024-05-10
CN108329337A (zh) 2018-07-27
PT3385267T (pt) 2021-11-23
NL1033190A1 (nl) 2007-04-23
HK1246300A1 (zh) 2018-09-07
CN103396427B (zh) 2018-04-13
US9862745B2 (en) 2018-01-09
NL1028639C2 (nl) 2007-01-17
CN1960996B (zh) 2016-04-20
ATE521612T1 (de) 2011-09-15
US20220204558A1 (en) 2022-06-30
DK1756121T3 (da) 2012-01-09
UY35578A (es) 2016-01-08
NL1033189C2 (nl) 2008-08-14
NL1028639A1 (nl) 2005-10-20
DK2377869T3 (da) 2014-04-14
NZ550522A (en) 2010-08-27
TWI386212B (zh) 2013-02-21
CA2738706A1 (en) 2005-10-20
UA90108C2 (uk) 2010-04-12
EP4008721A1 (en) 2022-06-08
HK1100004A1 (en) 2007-08-31
US20190330270A1 (en) 2019-10-31
PL3385267T3 (pl) 2022-02-14
CY1115336T1 (el) 2017-01-04
PT2377869E (pt) 2014-04-15
US10000529B2 (en) 2018-06-19
HUE065769T2 (hu) 2024-06-28
DOP2011000293A (es) 2011-12-15
IL219853A0 (en) 2012-06-28
EP1756121B1 (en) 2011-08-24
TW200616646A (en) 2006-06-01
MX367324B (es) 2019-08-15
IL219856A (en) 2015-05-31
CN108329337B (zh) 2021-06-25
KR100939598B1 (ko) 2010-02-01
CA2853272A1 (en) 2005-10-20
CN103396427A (zh) 2013-11-20
JP4558039B2 (ja) 2010-10-06
JP2016056180A (ja) 2016-04-21
AR049374A1 (es) 2006-07-26
NO338905B1 (no) 2016-10-31
NO20171939A1 (no) 2006-12-22
HK1257298A1 (zh) 2019-10-18
HRP20140339T1 (hr) 2014-05-09
EP1756121A2 (en) 2007-02-28
PE20060162A1 (es) 2006-04-07
JP5414625B2 (ja) 2014-02-12
US20150038706A1 (en) 2015-02-05
ES2899606T3 (es) 2022-03-14
CL2010000350A1 (es) 2011-01-28
UY28830A1 (es) 2005-09-30
US20200157143A1 (en) 2020-05-21
HK1164320A1 (en) 2012-10-19
PL2377869T3 (pl) 2014-07-31
UY34969A (es) 2015-02-27
FI4008721T3 (fi) 2024-03-19
ES2974758T3 (es) 2024-07-01
NO343966B1 (no) 2019-07-29
NL1033189A1 (nl) 2007-10-22
AR097310A2 (es) 2016-03-02
CA2560886A1 (en) 2005-10-20
RS62738B1 (sr) 2022-01-31
ES2457593T3 (es) 2014-04-28
US7714159B2 (en) 2010-05-11
EP4008721B1 (en) 2024-01-03
CN107474062A (zh) 2017-12-15
JP2013100378A (ja) 2013-05-23
EA200601795A1 (ru) 2007-04-27
NO20161350A1 (no) 2006-12-22
AU2005230930A1 (en) 2005-10-20
NO20191065A1 (no) 2006-12-22
LT4008721T (lt) 2024-03-25
EP2377869B1 (en) 2014-01-29
SG10201800972PA (en) 2018-03-28
WO2005097809A3 (en) 2006-02-16
HRP20110846T1 (hr) 2011-12-31
EP3385267A1 (en) 2018-10-10
IL219853A (en) 2015-05-31
US8283467B2 (en) 2012-10-09
PE20110075A1 (es) 2011-02-17
US20190112334A1 (en) 2019-04-18
PL1756121T3 (pl) 2012-02-29
EP3385267B1 (en) 2021-09-29

Similar Documents

Publication Publication Date Title
NZ606001A (en) Derivatives of 1-amino-2-cyclobutylethylboronic acid
CA2738706C (en) Synthesis of boronic ester and acid compounds
EP1690861A3 (en) A process for preparing duloxetine and intermediates for use therein
WO2007126812A3 (en) Process for preparation of hiv protease inhibitors
TNSN07403A1 (en) Method for preparation of optionally 2-substituted 1,6-dihydro-6-oxo-4-pyrimidinecarboxylic acids
TW200726754A (en) Chemical process
UA101482C2 (ru) Способ получения 2'-дезокси-5-азацитидина (децитабина)
EP1415968A4 (en) METHOD FOR PRODUCING AN ETHER CONNECTION
TNSN07465A1 (en) Organic compounds
IL200323A0 (en) Synthesis of glyt-1 inhibitors
PL356929A1 (en) Process for the synthesis of a known tetrazol derivative
AU2002220596A1 (en) Synthesis of r(+)alpha-lipoic acid
BRPI0507422A (pt) processo para produção de ácido 2,5-dimetilfenilacético
IL186979A0 (en) A process for the preparation of pyridine-methylsulfinyl compounds
IL173524A (en) Production process of optically pure 2-(4-hydroxyphenoxy)- propanoic acid compounds
EP1092720A3 (en) Process for the preparation of pyrazolo [4,3-d] pyrimidin-7-ones-3-pyridylsulphonyl compounds and intermediates thereof
EP1484311A4 (en) PROCESS FOR PRODUCING A CHAIN OLIGOLACTIC ACID ESTER
EP1652833A4 (en) PROCESS FOR THE PREPARATION OF 4-HYDROXYDIPHENYL ETHER
EP1666440A4 (en) METHOD FOR PRODUCING AN AROMATICALLY UNSATURATED COMPOUND
AU2006209556A1 (en) Process for production of 5-chloro-2,4-dihydroxypyridine
EP1700852A4 (en) PROCESS FOR PREPARING A 3- (4-TETRAHYDROPYRANYL) -3-OXOPROPIONIC ACID ELECTRIC COMPOSITION AND 4-ACYLTETRAHYDROPYRANE
DK1493801T3 (da) Fremgangsmåde til fremstilling af konjugerede fedtsyre
EP1724266A4 (en) PROCESS FOR PRODUCING 2,2,3,3-T TRAFLUOROOXETANE
EP1859862A4 (en) SYNTHESIS ACTION CATALYST AND METHOD FOR SYNTHESIS OF A COMPOUND THEREWITH
EP1541569A4 (en) PROCESS FOR PREPARING N-MONOALKYL-3-HYDROXY-3- (2-THIENYL) PROPANAMINE AND INTERMEDIATE PRODUCT

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 6 YEARS UNTIL 24 MAR 2015 BY HENRY HUGHES

Effective date: 20140114

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 24 MAR 2016 BY COMPUTER PACKAGES INC

Effective date: 20150303

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 24 MAR 2017 BY COMPUTER PACKAGES INC

Effective date: 20160301

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 24 MAR 2018 BY COMPUTER PACKAGES INC

Effective date: 20170302

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 24 MAR 2019 BY COMPUTER PACKAGES INC

Effective date: 20180302

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 24 MAR 2020 BY COMPUTER PACKAGES INC

Effective date: 20190302

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 24 MAR 2021 BY COMPUTER PACKAGES INC

Effective date: 20200303

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 24 MAR 2022 BY COMPUTER PACKAGES INC

Effective date: 20210309

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 24 MAR 2023 BY ANAQUA SERVICES

Effective date: 20220218

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 24 MAR 2024 BY ANAQUA SERVICES

Effective date: 20230222

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 24 MAR 2025 BY ANAQUA SERVICES

Effective date: 20240220

EXPY Patent expired